It is normal for viruses to change and evolve as they spread between people over time. When these changes become significantly different from the original virus, they are known as “variants.” To identify variants, scientists map the genetic material of viruses (known as sequencing) and then look for differences between them to see if they have changed.
Since the SARS-CoV-2 virus, the virus that causes COVID-19, has been spreading globally, variants have emerged and been identified in many countries around the world.
The current global epidemiology of SARS-CoV-2 is characterized by the predominance of the Delta variant, a declining trend in the proportion of Alpha, Beta and Gamma variants, and the emergence of Omicron, which was designated as a variant of concern (VOC) by WHO on November 26, 2021.
A variant is considered a variant of interest if there is initial scientific evidence of mutations that are suspected to cause significant changes, and is circulating widely (e.g., known to cause many clusters of infected people, or found in many countries).
There are 2 variants of interest (Mu and Lambda) that PAHO/WHO is continuing to monitor in case they become variants of concern.
A variant of interest becomes a variant of concern if it is known to spread more easily, cause more severe disease, escape the body’s immune response, change virus symptoms, or decrease effectiveness of known tools – such as public health measures, diagnostics, treatments and vaccines. There are 5 variants of concern (VOC) that PAHO/WHO is monitoring to date.
For the purpose of discussing variants in the media and the public, to make it easier for people to keep track of variants without linking their names to the places where they were first identified, as variants can emerge anywhere, at any time.
In accordance with WHO best practices for naming new diseases, some letters may not be used if they cause confusion in major languages or stigmatize certain groups. These WHO labels do not replace the existing scientific names of the variants, which convey important scientific information to researchers and scientists.
The Omicron variant, variant B.1.1.529, was first reported to WHO on 24 November 2021 and was . The classification was made on the advice of the Technical Advisory Group on Virus Evolution, based primarily on information from South Africa that showed that the variant has a large number of mutations and has caused a change in COVID-19 epidemiological trends in the country.
All variants are different. The Omicron variant has a large number of mutations which may mean the virus acts differently from other variants that are circulating.
There is now evidence that Omicron is spreading significantly faster than the Delta variant. Nevertheless, it is not clear yet if this is due to increased transmissibility, to increased re-infections, or both. Preliminary data suggest a reduced risk of severity, hospitalization or death for infections with Omicron compared to infections with Delta. This could be due to the intrinsic characteristics of the variant or to factors related to the populations where Omicron is spreading with significant levels of vaccination or previous infections with other variants.
WHO is working with technical partners to assess the performance of current vaccines against Omicron and will communicate these findings as soon as they become available. Preliminary data shows that available vaccines recognized by WHO continue to protect against severe disease, hospitalization and death regardless of the variant.
It is important to remember that re-infection even in vaccinated individuals might happen with all the variants, and therefore all the public health measures should be maintained and reinforced to prevent getting and spreading the virus. Currently, the Delta variant is dominant worldwide and COVID-19 vaccines approved by WHO are highly effective at protecting you from serious illness and death, including from infection with Delta.
Last update: 4 January 2022.
There is now evidence that Omicron is spreading significantly faster than the Delta variant. Nevertheless, it is not clear yet if this is due to increased transmissibility, to increased re-infections, or both.
Preliminary data suggest a reduced risk of severity, hospitalization or death for infections with Omicron compared to infections with Delta. This could be due to the intrinsic characteristics of the variant or to factors related to the populations where Omicron is spreading with significant levels of vaccination or previous infections with other variants.
PAHO/WHO continues to coordinate with a large number of researchers around the world to understand more about all variants of SARS-CoV-2, the virus that causes COVID-19, including Omicron. Many studies are needed, including assessments of:
- Transmissibility, or ease of spread from person to person, of Omicron as compared to other variants
- Severity of infection and re-infection with Omicron
- Performance of current COVID-19 vaccines against Omicron
- Performance of diagnostic tests, including antigen tests, to detect infection with Omicron
- Effectiveness of current treatments for management of patients with COVID-19 disease
WHO’s Technical Advisory Group on Virus Evolution will continue to monitor and evaluate the data as it becomes available and assess if mutations in the Omicron variant alter the behaviour of the virus.
In the Americas, the Regional COVID-19 Genomic Surveillance Network, coordinated by PAHO, regularly reports new sequences and scientific findings on SARS-CoV-2 genetic changes, which is critical to improve the development of diagnostic protocols, generate information for vaccine development, and to better understand the patterns of evolution and molecular epidemiology of SARS-CoV-2.
More information about COVID-19 Genomic Surveillance Regional Network
The Delta variant is a variant of concern classified by WHO on May 11, 2021 and it is currently the dominant variant circulating globally. Delta spreads more easily than earlier strains of the virus and is responsible for more cases and deaths worldwide. All WHO-COVID-19 approved vaccines currently in use are safe and effective in preventing severe disease and death against the Delta variant.
To protect yourself and others from COVID-19 variants:
- Get vaccinated, as soon as it is your turn
- Wash your hands frequently
- Wear a well-fitted mask over your mouth and nose
- Keep a distance of at least 1 metre from others
- Wear a well-fitted mask over your mouth and nose
- Avoid crowds
- Keep spaces well ventilated
- Cough or sneeze into a bent elbow or tissue
As with all viruses, SARS-COV-2, the virus that causes COVID-19, will continue to evolve as long as it continues to spread. The more that the virus spreads, the more pressure there is for the virus to change. So, the best way to prevent more variants from emerging is to stop the spread of the virus.
So, the best way to prevent more variants from emerging is to stop the spread of the virus and to contribute together to reduce the number of COVID-19 infections.
To protect yourself and others from COVID-19:
- Get vaccinated, as soon as it is your turn
- Wash your hands frequently
- Wear a well-fitted mask over your mouth and nose
- Keep a distance of at least 1 metre from others
- Avoid crowds
- Keep spaces well ventilated
- Cough or sneeze into a bent elbow or tissue
Viruses are constantly evolving and changing. Every time a virus replicates (makes copies of itself), there is the potential for there to be changes in its genetic material. Each of these changes is a “mutation.” A virus with one or more mutations is called a “variant” of the original virus.
Some mutations can lead to changes in important characteristics of the virus, including characteristics that affect its ability to spread and/or its ability to cause more severe illness and death.
We are still learning about the ways that variants impact vaccination.
The data we currently have available show us that COVID-19 vaccines are still very effective at preventing serious illness and death against all of the current variants of concern.
Currently, the delta variant is dominant in the Americas and the rest of the world, and the WHO-approved COVID-19 vaccines are highly effective in protecting against severe disease and death.
Regarding the new omicron variant of concern, WHO is working with technical partners to understand the potential impact of this variant on vaccine efficacy.
No vaccine is 100% effective. Although COVID-19 vaccines are very effective in protecting you against severe disease and death, some people will still get sick with COVID-19 after vaccination. They could also spread the virus to others who are not vaccinated. So, it is very important to continue to take protective measures, even after you have been fully vaccinated.
More questions and answers about COVID-19 vaccines
So far, the available evidence shows that WHO-approved vaccines are effective in reducing the likelihood of infection and preventing hospitalization and death from COVID-19.
WHO is working with technical partners to assess the performance of current vaccines against Omicron and will communicate these findings as soon as they become available. Preliminary data shows that available vaccines recognized by WHO continue to protect against severe disease, hospitalization and death regardless of the variant.
Currently, the Delta variant is dominant worldwide and COVID-19 vaccines approved by WHO are highly effective at protecting you from serious illness and death, including from infection with Delta.
It is important to remember that re-infection even in vaccinated individuals might happen with all the variants, and therefore all the public health measures should be maintained and reinforced to prevent getting and spreading the virus. Since no vaccine is 100% effective, it is necessary to continue with all preventive measures, even after vaccination: constant hand hygiene, use of masks, sneezing or coughing into the elbow, keeping a distance of at least 1 meter from other people, avoiding crowds and keeping spaces well ventilated, are measures that should continue to be practiced to prevent COVID-19 infection.
Last update: 4 January 2022
Available data shows that existing diagnostic tests currently used (both PCR and antigen-based rapid tests) remain able to detect infections with Omicron and other variants.
(Last update: 4 January 2022)